EAM
MRNS

Exome Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Exome Asset Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-163,100
Closed -$1.47M – 80
2024
Q1 		$1.47M Buy
+163,100
New +$1.47M 1.26% 37